A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis

Molecular Cancer Research

Volumn 1, Issue 2, 2002, Pages 96-102

  Tapon Bretaudière, Jacqueline ^a   Chabut, Delphine ^a   Zierer, Maximiliano ^a,b   Matou, Sabine ^a   Helley, Dominique ^a   Bros, Andrée ^a   Mourão, Paulo A S ^b   Fischer, Anne Marie ^a  

^a INSERM   (France)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHONDROITIN SULFATE; FIBROBLAST GROWTH FACTOR 2; FUCOSE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; HEPARIN; INTEGRIN; MATRIGEL;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ECHINODERM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FUCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ACTINS; ANIMALS; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CHONDROITIN SULFATES; COLLAGEN; CYTOSKELETON; DRUG COMBINATIONS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; FUCOSE; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; INTEGRINS; LAMININ; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; SEA CUCUMBERS; TIME FACTORS; UMBILICAL VEINS;

ANIMALIA; CUCUMIS SATIVUS; ECHINODERMATA; HOLOTHUROIDEA; MAMMALIA;

EID: 0036930525     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Risau, W. Mechanisms of angiogenesis. Nature, 386: 671-674, 1997.
2. Breier, G. and Risau, W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol., 6: 454-456, 1996.
3. Störmblad, S. and Cheresh, D. A. Cell adhesion and angiogenesis. Trends Cell Biol., 6: 462-468, 1996.
4. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69; 11-25, 1992.
5. Benelli, R. and Albini, A. In vitro models ofangiogenesis: the use of Matrigel. Int. J. Biol. Markers, 14: 243-246, 1999.
6. Ilan, N., Mahooti, S., and Madri, J. A. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci., 111: 3621-3631, 1998.
7. Davis, G. E. and Camarillo, C. W. Regulation of endothelial cell morphogenesis by integdns, mechanical forces, matrix guidance pathways. Exp. Cell Res., 216: 113-123, 1995.
8. DeLisser, H. M., Christofidou-Solomidou, M., Strieter, R. M., Burdick, M. D., Robinson, C. S., Wexler, R. S., Kerr, J. S., Garlanda, C., Merwin, J. R., Madri, J. A., and Albelda, S. M. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol., 151: 671-677, 1997.
9. Presta, M., Maier, J. A. M., Rusnati, M., and Ragnotti, G. Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine endothelial cells. J. Cell. Physiol., 141: 517-526, 1989.
10. Klein, S., Giancotti, F., Presta, M., Albelda, S. M., Buck, C. A., and Rifkin, D. B. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell, 4: 973-982, 1993.
11. Bikfalvi, A., Klein S., Pintucci, G., and Rifkin, D. B. Biological roles of fibroblast growth factor-2. Endocr. Rev., 18: 26-44, 1997.
12. Nugent, M. A. and Iozzo, R. V. Fibroblast growth factor-2. Int. J. Biochem. Cell Biol., 32: 115-120, 2000.
13. Hall, A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol., 10: 31-54, 1994.
14. Carey, D. Syndecans: multifunctional cell-surface co-receptors. Biochem. J., 327: 1-16, 1997.
15. Thomton, S. C., Mueller, E. M., and Levine, E. M. Human endothelial cells: use of heparin in cloning and long term serial cultivation. Science, 222: 623-625, 1983.
16. Gospodarowicz, D., Massoglia, S., Cheng, J., and Fujii, D. K. Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cell derived from bovine adrenal cortex, brain cortex and corpus luteum capillaries. J. Cell. Physiol., 127: 121-136, 1986.
17. Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Sclessinger, J., and Lax, I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell, 79: 1015-1024, 1994.
18. Gillis, C., Jonzon, B., and Haegerstrand, A. Effect of sera, basic growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells. Cell. Mol. Biol., 41: 1131-1138, 1995.
19. Klein-Soyer, C., Beretz, A., Cazenave, J. P., Winttendorp-Rechenmann, E., Vonesch, J. L., Rechenmann, R. V., Driot, F., and Maffrand, J. P. Sulfated polysaccharides modulate effects of acidic and basic fibroblast growth factors on repair of injured confluent human vascular endothelium. Arteriosclerosis, 9: 147-153, 1989.
20. Hämmerle, H., Betz, E., and Herr, D. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins. Vasa, 20: 207-214, 1991.
21. Giraux, J. L., Matou, S., Bros, A., Tapon-Bretaudière, J., Letoumeur, D., and Fischer, A. M. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin. Eur. J. Cell Biol., 77: 352-359, 1998.
22. Tapon-Bretaudière, J., Drouet, B., Matou, S., Mourão, P. A. S., Bros, A., and Fischer, A. M. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm. Thromb. Haemostasis, 84: 332-337, 2000.
23. Mourão, P. A. S., Pereira, M. S., Pavão, M. S., Mulloy, B., Tollefsen, D. M., Mowinckel, M. C., and Abilgaard, U. Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm: sulfated fucose branches on the polysaccharide account for its high anticoagulant action. J. Biol. Chem., 271: 23973-23984, 1996.
24. Mourão, P. A. S., Guimarães, M. A. M., Mulloy, B., Thomas, S., and Gray, E. Antithrombotic activity of a fucosylated chondroitin sulfate from echinoderm: sulfated fucose branches on the polysaccharide account for its antithrombotic action. Br. J. Haematol., 101: 647-652, 1998.
25. Pacheco, R. G., Vicente, C. P., Zancan, P., and Mourão, P. A. S. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from echinoderm. Blood Coagul. Fibrinolysis, 11: 563-573, 2000.
26. Kinsella, J. L., Grant, D. S., Weeks, B. S., and Kleinman, H. K. Protein kinase C regulates endothelial cell tube formation on basement membrane matrix. Matrigel. Exp. Cell Res., 199: 56-62, 1992.
27. Duckworth, B. C. and Cantley, L. C. Conditional inhibition of the Mitogenactivated protein kinase cascade by wortmannin. J. Biol. Chem., 272: 27665-27670, 1997.
28. Kay, E. P., Park, S. Y., Ko, M. K., and Lee, S. C. Fibroblast growth factor 2 uses PLC-γ1 for cell proliferation and PI3-kinase for alteration of cell shape and cell proliferation in corneal endothelial cells. Mol. Vis., 4: 22-31, 1998.
29. Klint, P., Kanda, S., Kloog, Y., and Claesson-Welsh, L. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene, 18: 3354-3364, 1999.
30. Matou, S., Helley, D., Chabut, D., Bros, A., and Fischer, A-M. Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. Thromb. Res., 106: 213-221, 2002.
31. Mouão, P. A. S. and Bastos, I. G. Highly acidic glycans from sea cucumbers. Isolation and fractionation of fucose-rich sulfated polysaccharides from the body wall of Ludwigothurea grisea. Eur. J. Biochem., 166: 639-645, 1987.
32. Vieira, R. P. and Mourão, P. A. S. Occurrence of a unique fucose-branched chondroifin sulfate in the body wall of a sea cucumber. J. Biol. Chem., 263: 18176-18183, 1988.
33. Vieira, R. P., Mulloy, B., and Mourão, P. A. S. Structure ofa fucose-branched chondroitin sulfate from sea cucumber: evidence for the presence of 3-O-sulfo-βD-glucuronosyl residues. J. Biol. Chem., 266: 13530- 13536, 1991.
34. Jaffe, E. A., Nachman, E. L., Becker, C. G., and Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52: 2745-2756, 1973.